The novel HLA‐B*13:179 variant detected by next generation sequencing in a Chinese individual
HLA · 2023
DOI: 10.1111/tan.15153 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2023. Verfasst von Yan-Ping Zhong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Institute of Transfusion Medicine, Shenzhen Blood Center, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, East Asian People. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 3 Literaturangaben.
Abstract (Originalsprache)
HLA‐B*13:179 differs from HLA‐B*13:99 by one nucleotide substitution at position 829(A>G) in exon 4.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shenzhen Institute of Transfusion Medicine, Shenzhen Blood Center, Shenzhen, Guangdong, China.
ORCID-Profile: Yan-Ping Zhong, Zhan-Rou Quan, Liu-Mei He, Hong-Yan Zou
Zitieren
APA
Zhong, Y. P., Quan, Z. R., He, L. M., & Zou, H. Y. (2023). The novel HLA‐B*13:179 variant detected by next generation sequencing in a Chinese individual. HLA. https://doi.org/10.1111/tan.15153
Vancouver
Zhong YP, Quan ZR, He LM, Zou HY. The novel HLA‐B*13:179 variant detected by next generation sequencing in a Chinese individual. HLA. 2023. doi:10.1111/tan.15153
BibTeX
@article{Zhong2023,
author = {Zhong, Yan-Ping and Quan, Zhan-Rou and He, Liu-Mei and Zou, Hong-Yan},
title = {The novel HLA‐B*13:179 variant detected by next generation sequencing in a Chinese individual},
journal = {HLA},
year = {2023},
doi = {10.1111/tan.15153}
}
EUVIMED